Edition:
United States

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

352.60SEK
19 Feb 2018
Change (% chg)

-3.40kr (-0.96%)
Prev Close
356.00kr
Open
345.20kr
Day's High
356.00kr
Day's Low
345.20kr
Volume
931
Avg. Vol
10,903
52-wk High
613.00kr
52-wk Low
290.00kr

Chart for

About

Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi... (more)
No analyst recommendations are available for .

Overall

Beta: 0.64
Market Cap(Mil.): kr4,145.31
Shares Outstanding(Mil.): 11.64
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 21.75 17.27
EPS (TTM): -- -- --
ROI: -- 12.13 35.43
ROE: -- 15.30 17.10

BRIEF-Probi: Clinical Trial Confirms Immune Enhancing Impact Of Probi Defendum

* LARGEST CLINICAL TRIAL CONFIRMS THE IMMUNE ENHANCING IMPACT OF PROBI DEFENDUM® AND SHEDS NEW LIGHT ON THE MECHANISM

Feb 06 2018

BRIEF-Probi Signs Agreement For Product Launch In North America

* SIGNED MAJOR AGREEMENT FOR LAUNCH OF FUNCTIONAL FOOD PRODUCT IN NORTH AMERICA

Dec 12 2017

BRIEF-Probi Q3 operating profit down at SEK 16.6‍​ million

* Q3 NET SALES SEK ‍​133.5 MILLION VERSUS SEK 89.2 MILLION YEAR AGO

Oct 25 2017

Earnings vs. Estimates